NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression.
NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression.
复制标题
NLRP3 炎症小体依赖性高迁移率族盒 1 增加参与 Tau 过度表达引起的认知功能障碍
DOI:
10.3389/fnagi.2021.721474
复制
发表时间:
2021
影响因子:
4.8
通讯作者:
Zhou YG
中科院分区:
文献类型:
--
作者:
Zhao Y;Tan SW;Huang ZZ;Shan FB;Li P;Ning YL;Ye SY;Zhao ZA;Du H;Xiong RP;Yang N;Peng Y;Chen X;Zhou YG
Tau hyperphosphorylation is a characteristic alteration present in a range of neurological conditions, such as traumatic brain injury (TBI) and neurodegenerative diseases. Treatments targeting high-mobility group box protein 1 (HMGB1) induce neuroprotective effects in these neuropathologic conditions. However, little is known about the interactions between hyperphosphorylated tau and HMGB1 in neuroinflammation. We established a model of TBI with controlled cortical impacts (CCIs) and a tau hyperphosphorylation model by injecting the virus encoding human P301S tau in mice, and immunofluorescence, western blotting analysis, and behavioral tests were performed to clarify the interaction between phosphorylated tau (p-tau) and HMGB1 levels. We demonstrated that p-tau and HMGB1 were elevated in the spatial memory-related brain regions in mice with TBI and tau-overexpression. Animals with tau-overexpression also had significantly increased nucleotide-binding oligomerization domain-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation, which manifested as increases in apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), activating caspase-1 and interleukin 1 beta (IL-1β) levels. In addition, NLRP3–/– mice and the HMGB1 inhibitor, glycyrrhizin, were used to explore therapeutic strategies for diseases with p-tau overexpression. Compared with wild-type (WT) mice with tau-overexpression, downregulation of p-tau and HMGB1 was observed in NLRP3–/– mice, indicating that HMGB1 alterations were NLRP3-dependent. Moreover, treatment with glycyrrhizin at a late stage markedly reduced p-tau levels and improved performance in the Y- and T-mazes and the ability of tau-overexpressing mice to build nests, which revealed improvements in spatial memory and advanced hippocampal function. The findings identified that p-tau has a triggering role in the modulation of neuroinflammation and spatial memory in an NLRP3-dependent manner, and suggest that treatment with HMGB1 inhibitors may be a better therapeutic strategy for tauopathies.
登录
查看更多内容
DOI:
10.1016/j.bbi.2017.11.018
发表时间:
2018-08
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
Kigerl KA;Lai W;Wallace LM;Yang H;Popovich PG
通讯作者:
Popovich PG
影响因子:
16.2
作者:
Kaufman SK;Sanders DW;Thomas TL;Ruchinskas AJ;Vaquer-Alicea J;Sharma AM;Miller TM;Diamond MI
通讯作者:
Diamond MI
影响因子:
5.7
作者:
Chavan, Sangeeta S.;Huerta, Patricio T.;Diamond, Betty
通讯作者:
Diamond, Betty
影响因子:
3.3
作者:
Chen, S.;An, F. -M.;Gao, X. -D.
通讯作者:
Gao, X. -D.
影响因子:
5
作者:
Hou, Lei;Yang, Zhongwei;Wang, Xiangrui
通讯作者:
Wang, Xiangrui